XPO enters into $1.1B term loan refinancing and new $600M revolver

XPO, Inc.

XPO (XPO) entered a Refinancing Amendment (No.10) on Feb 26, 2025 for up to $700M Term Loan B-2 (matures May 2028) and $400M Term Loan B-3 (matures Feb 2031).
The company also entered a new $600M Revolving Credit Facility maturing April 2030 with Wells Fargo as agent, replacing the prior ABL credit facility.
Proceeds from the term loan facilities will refinance all existing term loan indebtedness under the prior credit agreement.
The refinancing includes release of liens on fee-owned real property, rolling stock, and other titled assets.

item 1.01 item 1.02 item 2.03 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-017441
form_type: 8-K
ticker: XPO
cik: 0001166003
company_name: XPO, Inc.
filed_at: 2025-02-26T23:59:59+00:00
discovered_at: 2026-05-14T18:03:03.068485+00:00
generated_at: 2026-05-26T03:21:18.579092+00:00
sec_items: ["1.01", "1.02", "2.03", "9.01"]
event_type: debt
sentiment: neutral
materiality_score: 0.8
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-017441
json_url: https://secwatch.observer/filing/0001104659-25-017441.json
markdown_url: https://secwatch.observer/filing/0001104659-25-017441.md
text_url: https://secwatch.observer/filing/0001104659-25-017441.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1166003/000110465925017441/0001104659-25-017441-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1166003/000110465925017441/tm257583d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-017441

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.